$200.00
-8-3.85%
At close: -
$282.50
82.541.25%
After Hours: Feb 28, 9:28 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Genmab in recent months.
Browse guidance and forecast on all stocks.